INSURANCE/HEALTH: Requires drug manufacturers to limit pricing of GLP-1 medications for health insurance plans (OR INCREASE GF EX See Note)

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 4 Sponsors

HB920 Original — · 630 words Open full page ↗

HLS 26RS-178 ORIGINAL

2026 Regular Session

HOUSE BILL NO. 920

BY REPRESENTATIVE JORDAN

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in

PASSAGE PROBABILITY

2.6% Unlikely

Why this number

Stage base In Committee — base rate 29%, measured from LA's completed sessions
Momentum -5 28/100 from the pace of recorded action
Time since last action -22 226 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.